209 related articles for article (PubMed ID: 10210183)
1. Protein-protein recognition: an experimental and computational study of the R89K mutation in Raf and its effect on Ras binding.
Zeng J; Fridman M; Maruta H; Treutlein HR; Simonson T
Protein Sci; 1999 Jan; 8(1):50-64. PubMed ID: 10210183
[TBL] [Abstract][Full Text] [Related]
2. Nuclear magnetic resonance and molecular dynamics studies on the interactions of the Ras-binding domain of Raf-1 with wild-type and mutant Ras proteins.
Terada T; Ito Y; Shirouzu M; Tateno M; Hashimoto K; Kigawa T; Ebisuzaki T; Takio K; Shibata T; Yokoyama S; Smith BO; Laue ED; Cooper JA
J Mol Biol; 1999 Feb; 286(1):219-32. PubMed ID: 9931261
[TBL] [Abstract][Full Text] [Related]
3. Molecular dynamics simulations of the Ras:Raf and Rap:Raf complexes.
Zeng J; Treutlein HR; Simonson T
Proteins; 1999 Apr; 35(1):89-100. PubMed ID: 10090289
[TBL] [Abstract][Full Text] [Related]
4. Massive sequence perturbation of the Raf ras binding domain reveals relationships between sequence conservation, secondary structure propensity, hydrophobic core organization and stability.
Campbell-Valois FX; Tarassov K; Michnick SW
J Mol Biol; 2006 Sep; 362(1):151-71. PubMed ID: 16916524
[TBL] [Abstract][Full Text] [Related]
5. The transition state of the ras binding domain of Raf is structurally polarized based on Phi-values but is energetically diffuse.
Campbell-Valois FX; Michnick SW
J Mol Biol; 2007 Feb; 365(5):1559-77. PubMed ID: 17137592
[TBL] [Abstract][Full Text] [Related]
6. Specific amino acid recognition by aspartyl-tRNA synthetase studied by free energy simulations.
Archontis G; Simonson T; Moras D; Karplus M
J Mol Biol; 1998 Feb; 275(5):823-46. PubMed ID: 9480772
[TBL] [Abstract][Full Text] [Related]
7. Conformation of the Ras-binding domain of Raf studied by molecular dynamics and free energy simulations.
Zeng J; Treutlein HR; Simonson T
Proteins; 1998 May; 31(2):186-200. PubMed ID: 9593192
[TBL] [Abstract][Full Text] [Related]
8. Mitogenic signaling of Ras is regulated by differential interaction with Raf isozymes.
Weber CK; Slupsky JR; Herrmann C; Schuler M; Rapp UR; Block C
Oncogene; 2000 Jan; 19(2):169-76. PubMed ID: 10644994
[TBL] [Abstract][Full Text] [Related]
9. Fusion of the binding domain of Raf-1 kinase with green fluorescent protein for activated Ras detection by fluorescence correlation spectroscopy.
Trier U; Olah Z; Kleuser B; Schäfer-Korting M
Pharmazie; 1999 Apr; 54(4):263-8. PubMed ID: 10234739
[TBL] [Abstract][Full Text] [Related]
10. raf RBD and ubiquitin proteins share similar folds, folding rates and mechanisms despite having unrelated amino acid sequences.
Vallée-Bélisle A; Turcotte JF; Michnick SW
Biochemistry; 2004 Jul; 43(26):8447-58. PubMed ID: 15222756
[TBL] [Abstract][Full Text] [Related]
11. Solution structure and functional analysis of the cysteine-rich C1 domain of kinase suppressor of Ras (KSR).
Zhou M; Horita DA; Waugh DS; Byrd RA; Morrison DK
J Mol Biol; 2002 Jan; 315(3):435-46. PubMed ID: 11786023
[TBL] [Abstract][Full Text] [Related]
12. Normal and oncogenic p21ras proteins bind to the amino-terminal regulatory domain of c-Raf-1.
Zhang XF; Settleman J; Kyriakis JM; Takeuchi-Suzuki E; Elledge SJ; Marshall MS; Bruder JT; Rapp UR; Avruch J
Nature; 1993 Jul; 364(6435):308-13. PubMed ID: 8332187
[TBL] [Abstract][Full Text] [Related]
13. Change in protein flexibility upon complex formation: analysis of Ras-Raf using molecular dynamics and a molecular framework approach.
Gohlke H; Kuhn LA; Case DA
Proteins; 2004 Aug; 56(2):322-37. PubMed ID: 15211515
[TBL] [Abstract][Full Text] [Related]
14. A detailed thermodynamic analysis of ras/effector complex interfaces.
Kiel C; Serrano L; Herrmann C
J Mol Biol; 2004 Jul; 340(5):1039-58. PubMed ID: 15236966
[TBL] [Abstract][Full Text] [Related]
15. What makes Ras an efficient molecular switch: a computational, biophysical, and structural study of Ras-GDP interactions with mutants of Raf.
Filchtinski D; Sharabi O; Rüppel A; Vetter IR; Herrmann C; Shifman JM
J Mol Biol; 2010 Jun; 399(3):422-35. PubMed ID: 20361980
[TBL] [Abstract][Full Text] [Related]
16. A small peptide derived from the aminoterminus of c-Raf-1 inhibits c-Raf-1/Ras binding.
Niehof M; Radziwill G; Klauser S; Moelling K
Biochem Biophys Res Commun; 1995 Jan; 206(1):46-50. PubMed ID: 7818549
[TBL] [Abstract][Full Text] [Related]
17. On the role of electrostatic interactions in the design of protein-protein interfaces.
Sheinerman FB; Honig B
J Mol Biol; 2002 Apr; 318(1):161-77. PubMed ID: 12054776
[TBL] [Abstract][Full Text] [Related]
18. Factors determining electrostatic fields in molecular dynamics simulations of the Ras/effector interface.
Ensign DL; Webb LJ
Proteins; 2011 Dec; 79(12):3511-24. PubMed ID: 21748802
[TBL] [Abstract][Full Text] [Related]
19. Insights into protein-protein binding by binding free energy calculation and free energy decomposition for the Ras-Raf and Ras-RalGDS complexes.
Gohlke H; Kiel C; Case DA
J Mol Biol; 2003 Jul; 330(4):891-913. PubMed ID: 12850155
[TBL] [Abstract][Full Text] [Related]
20. In vitro inhibition of Ras-Raf association by short peptides.
Barnard D; Sun H; Baker L; Marshall MS
Biochem Biophys Res Commun; 1998 Jun; 247(1):176-80. PubMed ID: 9636675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
